IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. & En...
November 03 2016 - 2:16PM
Business Wire
Lundin Law PC, a shareholder rights firm, announces a class
action lawsuit against Spectrum Pharmaceuticals, Inc. (“Spectrum”
or the “Company”) (Nasdaq: SPPI) concerning possible violations of
federal securities laws between February 28, 2013 and September 16,
2016 inclusive (the “Class Period”). Investors, who purchased or
otherwise acquired shares during the Class Period, are encouraged
to contact the firm in advance of the November 21, 2016 lead
plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esquire, of Lundin Law PC, at
888-713-1033, or e-mail him at brian@lundinlawpc.com.
No class has been certified in the above action. Until a class
is certified, you are not considered represented by an attorney.
You may also choose to do nothing and be an absent class
member.
According to the Complaint, Spectrum made false and/or
misleading statements and/or failed to disclose that: the FDA
previously questioned whether the data from the 611 and 612 Studies
(the names of the Phase 3 studies for apaziquone) were clinically
significant; that the FDA instructed the Company in December 2012
not to submit the New Drug Application based on data from the 611
and 612 Studies; and that as a result of the above, the Company’s
public statements regarding its business, operations and prospects
were materially false and misleading at all relevant times.
Lundin Law PC was founded by Brian Lundin, a securities
litigator based in Los Angeles dedicated to upholding the rights of
shareholders.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161103006491/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2023 to Apr 2024